Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study on Delayed Selective Sentinel Node Biopsy for Patients Undergoing Mastectomy for Ductal Carcinoma in Situ

NCT05912569 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT05912569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05912569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study on Delayed Selective Sentinel Node Biopsy for Patients Undergoing Mastectomy for Ductal Carcinoma in Situ
Lead sponsor
Seoul National University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
June 13, 2023
Completion date
April 28, 2025
Enrollment
84 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dcis